These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26297163)

  • 1. [Infertility over forty: Pros and cons of IVF].
    Belaisch-Allart J; Maget V; Mayenga JM; Grefenstette I; Chouraqui A; Belaid Y; Kulski O
    Gynecol Obstet Fertil; 2015 Sep; 43(9):599-603. PubMed ID: 26297163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assisted reproductive technologies in HIV patients: Which results and which strategy in France in 2019?].
    Ninive C; Ferraretto X; Gricourt S; Llabador MA; Lepage J; Gauché-Cazalis C; Epelboin S; Peigné M
    Gynecol Obstet Fertil Senol; 2019 Apr; 47(4):362-369. PubMed ID: 30753900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management in medically assisted procreation of an infertile couple].
    Roux C; Berdin A; Amiot C
    Rev Prat; 2014 Dec; 64(10):1432. PubMed ID: 25665329
    [No Abstract]   [Full Text] [Related]  

  • 4. Should IVF be used as first-line treatment or as a last resort? A debate presented at the 2013 Canadian Fertility and Andrology Society meeting.
    Huang LN; Tan J; Hitkari J; Dahan MH
    Reprod Biomed Online; 2015 Feb; 30(2):128-36. PubMed ID: 25498596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out-of-pocket fertility patient expense: data from a multicenter prospective infertility cohort.
    Wu AK; Odisho AY; Washington SL; Katz PP; Smith JF
    J Urol; 2014 Feb; 191(2):427-32. PubMed ID: 24018235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the demographic profile of patients treated for infertility using assisted reproductive techniques in 2005-2010].
    Milewski R; Milewska AJ; Czerniecki J; Leśniewska M; Wołczyński S
    Ginekol Pol; 2013 Jul; 84(7):609-14. PubMed ID: 24032272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assisted reproductive technologies place].
    Amar-Hoffet A; Hédon B; Belaisch-Allart J
    J Gynecol Obstet Biol Reprod (Paris); 2010 Dec; 39(8 Suppl 2):S88-99. PubMed ID: 21185490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of Infertility and In Vitro Fertilization Treatment among Married Couples in Anambra State, Nigeria.
    Okafor NI; Joe-Ikechebelu NN; Ikechebelu JI
    Afr J Reprod Health; 2017 Dec; 21(4):55-66. PubMed ID: 29624951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment options for age-related infertility].
    Belaisch-Allart J
    Rev Prat; 2010 Jun; 60(6):819-23. PubMed ID: 20623902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What is the validity limit of patient reimbursement? Is age a criterion for refusal? Yes....].
    Belaisch-Allart J
    J Gynecol Obstet Biol Reprod (Paris); 2005 Nov; 34(7 Pt 2):5S18-5S21. PubMed ID: 16340898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and management of infertility: a population-based study in UK primary care.
    Wilkes S; Chinn DJ; Murdoch A; Rubin G
    Fam Pract; 2009 Aug; 26(4):269-74. PubMed ID: 19502575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Male age in assisted reproductive technologies: Is there a limit?].
    Belaisch-Allart J; Ouazana M; Bailly M; Selva J; Kulski O; Boitrelle F
    Gynecol Obstet Fertil; 2016 Dec; 44(12):712-715. PubMed ID: 27839714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Twenty years of in vitro fertilization: realization and questions for the future].
    van Steirteghem A
    Verh K Acad Geneeskd Belg; 2001; 63(3):193-240; discussion 240-1. PubMed ID: 11499344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assisted reproductive techniques in women aged 38 years or more].
    Lamarche C; Lévy R; Felloni B; de Mouzon J; Denis-Belicard E; Huss M; Maubon I; Aknin I; Seffert P
    Gynecol Obstet Fertil; 2007 May; 35(5):420-9. PubMed ID: 17459756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of conventional assisted reproductive technologies and history of cancer: what are the results?].
    Robin G; Decanter C
    Gynecol Obstet Fertil; 2014 Jan; 42(1):27-31. PubMed ID: 24398020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Committee for Monitoring Assisted Reproductive Technologies (ICMART) world report: assisted reproductive technology 2004.
    Sullivan EA; Zegers-Hochschild F; Mansour R; Ishihara O; de Mouzon J; Nygren KG; Adamson GD
    Hum Reprod; 2013 May; 28(5):1375-90. PubMed ID: 23442757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assisted reproductive technology surveillance -- United States, 2010.
    Sunderam S; Kissin DM; Crawford S; Anderson JE; Folger SG; Jamieson DJ; Barfield WD;
    MMWR Surveill Summ; 2013 Dec; 62(9):1-24. PubMed ID: 24304902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How far can we go to oocyte donation? Debates on the risks of late pregnancies].
    Lombart M; Cabry R; Boulard V; Lourdel E; Lanta S; Verhoest P; Copin H; Gondry J; Merviel P
    Gynecol Obstet Fertil; 2013 Nov; 41(11):672-7. PubMed ID: 24183579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical review 100: Evaluation and treatment of the infertile couple.
    Forti G; Krausz C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4177-88. PubMed ID: 9851748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In-vitro fertilization: advantage and disadvantage of covering the costs of IVF/ICSI by the health insurance in Switzerland].
    Wunder-Galié D; Hohlfeld P; de Ziegler D
    Rev Med Suisse; 2009 Oct; 5(222):2106-8, 2110. PubMed ID: 19947454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.